InvestorsHub Logo
Followers 69
Posts 6506
Boards Moderated 0
Alias Born 02/10/2010

Re: None

Thursday, 10/17/2019 11:41:04 AM

Thursday, October 17, 2019 11:41:04 AM

Post# of 330443
What Happens When Mundipharma Forms Strategic Partnership?

Cidara Therapeutics and Mundipharma Form Strategic Partnership to Develop and Commercialize Rezafungin
Published: Sep 03, 2019

Sept. 3, 2019 10:00 UTC
Collaboration combines strengths to develop and commercialize life-saving antifungal treatment and prophylaxis, an area of high unmet medical need

* Mundipharma acquires exclusive rights to develop and commercialize rezafungin in all markets outside of the United States and Japan, which will be retained by Cidara

* Cidara to receive upfront payment of $30 million and equity investment of $9 million, co-development funding, development milestones and tiered royalty stream

* Total transaction value could exceed $568 million


This is what it looks like when Mundipharam enters a Strategic Partnership with a company.

https://www.biospace.com/article/releases/cidara-therapeutics-and-mundipharma-form-strategic-partnership-to-develop-and-commercialize-rezafungin-/